Clinical Trials
- Phase II Clinical Trial of Carfilzomib
- PRESS RELEASE
- The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
- Phase I/II Clinical Trials of TORISEL™ in Combination with VELCADE®
- PRESS RELEASE
- The Multiple Myeloma Research Consortium Commences Phase I/II Combination Study for the Treatment of Multiple Myeloma
- Phase II Clinical Trial of LBH859
- PRESS RELEASE
- Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
- Phase I Clinical Trial of VELCADE® in Combination with Tipifarnib
- PRESS RELEASE
- Multiple Myeloma Research Consortium (MMRC), Emory University Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
- Phase I Trial of NPI-0052
- PRESS RELEASE
- The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma
- Phase I Clinical Trial of Perifosine (KRX-0401) in Combination with REVLIMID® and dexamethasone
- PRESS RELEASE
- The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
- Phase I Clinical Trial of TKI258 (CHIR-258)
- ABSTRACT
- Phase I trial of chir-258 in multiple myeloma
- PRESS RELEASE
- Chiron and the Multiple Myeloma Research Consortium Announce Initiation of Phase I Clinical Trial for CHIR-258
